BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33383467)

  • 1. Prognostic value of modified systemic inflammatory score in patients with newly diagnosed high-grade gliomas.
    Xie T; Guo X; Duan H; He Z; Mou Y
    Clin Neurol Neurosurg; 2021 Feb; 201():106428. PubMed ID: 33383467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corpus callosum involvement and postoperative outcomes of patients with gliomas.
    Chen KT; Wu TW; Chuang CC; Hsu YH; Hsu PW; Huang YC; Lin TK; Chang CN; Lee ST; Wu CT; Tseng CK; Wang CC; Pai PC; Wei KC; Chen PY
    J Neurooncol; 2015 Sep; 124(2):207-14. PubMed ID: 26033546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic role of preoperative systemic immune-inflammation index and albumin/globulin ratio in patients with newly diagnosed high-grade glioma.
    Liang R; Li J; Tang X; Liu Y
    Clin Neurol Neurosurg; 2019 Sep; 184():105397. PubMed ID: 31306893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low preoperative prognostic nutritional index predicts poor survival in patients with newly diagnosed high-grade gliomas.
    He ZQ; Ke C; Al-Nahari F; Duan H; Guo CC; Wang Y; Zhang XH; Chen YS; Liu ZG; Wang J; Chen ZP; Jiang XB; Mou YG
    J Neurooncol; 2017 Apr; 132(2):239-247. PubMed ID: 28078639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
    Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
    J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cumulative prognostic score based on pretreatment plasma fibrinogen and serum albumin levels in patients with newly diagnosed high-grade gliomas.
    He ZQ; Duan H; Ke C; Zhang XH; Guo CC; Al-Nahari F; Zhang J; Chen ZH; Chen YS; Liu ZG; Wang J; Chen ZP; Jiang XB; Mou YG
    Oncotarget; 2017 Jul; 8(30):49605-49614. PubMed ID: 28548947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer.
    Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P
    Gastric Cancer; 2019 Mar; 22(2):403-412. PubMed ID: 29982861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-dependent association of preoperative hematologic markers with glioma grade and progression.
    Xu W; Wang D; Zheng X; Ou Q; Huang L
    J Neurooncol; 2018 Apr; 137(2):279-287. PubMed ID: 29260361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of systemic inflammation score in patients who undergo hepatic resection for hepatocellular carcinoma.
    Inokuchi S; Itoh S; Yoshizumi T; Morinaga A; Toshima T; Takeishi K; Nagao Y; Harada N; Ikegami T; Shimokawa M; Mori M
    Langenbecks Arch Surg; 2021 May; 406(3):773-779. PubMed ID: 33595705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Preoperative Systemic Cellular Inflammatory Markers in Gliomas: A Systematic Review and Meta-Analysis.
    Wang DP; Kang K; Lin Q; Hai J
    Clin Transl Sci; 2020 Jan; 13(1):179-188. PubMed ID: 31550075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
    Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
    J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma.
    Chang Y; An H; Xu L; Zhu Y; Yang Y; Lin Z; Xu J
    Br J Cancer; 2015 Aug; 113(4):626-33. PubMed ID: 26135896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores.
    Dolan RD; McSorley ST; Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
    Br J Cancer; 2018 Jul; 119(1):40-51. PubMed ID: 29789606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified Systemic Inflammation Score Is an Independent Predictor of Long-Term Outcome in Patients Undergoing Surgery for Adenocarcinoma of the Esophagogastric Junction.
    Xiong J; Kang W; Ma F; Liu H; Ma S; Li Y; Jin P; Hu H; Tian Y
    Front Surg; 2021; 8():622821. PubMed ID: 34820414
    [No Abstract]   [Full Text] [Related]  

  • 15. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
    Fu X; Li T; Dai Y; Li J
    BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era.
    Sun F; Zhu J; Lu S; Zhen Z; Wang J; Huang J; Ding Z; Zeng M; Sun X
    BMC Cancer; 2018 Jan; 18(1):5. PubMed ID: 29291712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amide proton transfer imaging might predict survival and IDH mutation status in high-grade glioma.
    Joo B; Han K; Ahn SS; Choi YS; Chang JH; Kang SG; Kim SH; Zhou J; Lee SK
    Eur Radiol; 2019 Dec; 29(12):6643-6652. PubMed ID: 31175415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
    Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
    Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival.
    Kiviniemi A; Gardberg M; Frantzén J; Parkkola R; Vuorinen V; Pesola M; Minn H
    J Neurooncol; 2015 Sep; 124(2):237-45. PubMed ID: 26033547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy.
    Zhao K; Wang C; Shi F; Huang Y; Ma L; Li M; Song Y
    BMC Cancer; 2021 Jan; 21(1):66. PubMed ID: 33446134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.